J.P. Turner & Co Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LTI
BIT
J.P. Turner & Co Capital Management's BMY Position: Q3 2015 in Review
J.P. Turner & Co Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 32% in Q3 2015, selling an estimated $187K and leaving 6,395 shares worth $378K. The position accounts for 0.39% of the portfolio, ranked #86.
J.P. Turner & Co Capital Management first reported a position in BMY in Q4 2014 and has held it in 4 quarters since. The position peaked at $622K in Q2 2015. 1,453 funds tracked by Wall St. Rank hold BMY as of Q3 2015.
- J.P. Turner & Co Capital Management held 6,395 shares of Bristol-Myers Squibb worth $378K as of Q3 2015.
- J.P. Turner & Co Capital Management sold 2,946 Bristol-Myers Squibb shares in Q3 2015, an estimated $187K.
- Bristol-Myers Squibb made up 0.39% of J.P. Turner & Co Capital Management's portfolio in Q3 2015, its #86 holding.
- J.P. Turner & Co Capital Management first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 4 quarters since.
- J.P. Turner & Co Capital Management's Bristol-Myers Squibb position peaked at $622K in Q2 2015.
- 1,453 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2015.
Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.